EUVIMEDEUVIMED entdecken
Open Access

Indocyanine Green–Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients

Daniela Duarte-Bateman iD, Alan Shen, Yanwen Chen, Jorge Arpi-Palacios iD, Eduardo Williams, Viren Patel, Rebecca Knackstedt, Brian R Gastman

Journal of Surgical Oncology · 2026-06 · 133 (8) · 1031-1038

DOI: 10.1002/jso.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 19.04.2026. Verfasst von Daniela Duarte-Bateman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Melanoma, Indocyanine Green, Sentinel Lymph Node Biopsy, Skin Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The sentinel lymph node biopsy (SLNB) remains the standard for identifying micrometastasis in melanoma. In this study, we utilized our prospectively maintained database to assess whether adding indocyanine green (ICG) fluorescence imaging to radioisotope lymphoscintigraphy improved sentinel node detection and, consequently, clinical outcomes.

Methods

Consecutive patients with cutaneous melanoma who underwent dual technique SLNB by the senior author (B.R.G.) from 2012 to 2022 were enrolled. All patients with a negative SLNB result were subjected to a minimum follow‐up period of 12 months. Positive and false‐negative rates were calculated, and recurrence‐free survival (RFS) was used as a measure of clinical outcomes.

Results

A total of 1267 patients were identified. The average age was 62 years, with 526 females (41.6%). The mean Breslow depth was 1.82 mm (range 0.2–24 mm). Among 3403 SLNs sampled, 358 were positive (91.1% identified by both modalities). The false‐negative rate was 8.5% (25/293), and the median time to recurrence was 13.7 months (range: 2.8–60.4 months). The 12‐month RFS for stages IA‐IIC were 99%, 98%, 95%, 97%, and 84%, respectively ( p = 0.016).

Conclusions

These findings support the use of an ICG‐based dual technique in SLNB for melanoma, demonstrating diagnostic precision with excellent patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaIndocyanine GreenSentinel Lymph Node BiopsySkin NeoplasmsHumansFemaleMiddle AgedMaleAgedAdultAged, 80 and overProspective StudiesFollow-Up StudiesLymphoscintigraphyYoung AdultPrognosisCutaneous Malignant MelanomaColoring AgentsSentinel Lymph NodeNeoplasm Recurrence, LocalLymphatic Metastasis

Stichwörter der Autor:innen

indocyanine greenmelanomarecurrence‐free survivalsentinel lymph node biopsy

Substanzen

Indocyanine GreenColoring Agents

Autor:innen und Institutionen

  • Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
  • Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.

ORCID-Profile: Daniela Duarte-Bateman, Jorge Arpi-Palacios

Zitieren

APA

Duarte-Bateman, D., Shen, A., Chen, Y., Arpi-Palacios, J., Williams, E., Patel, V., Knackstedt, R., & Gastman, B. R. (2026). Indocyanine Green–Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients. Journal of Surgical Oncology, 133(8), 1031-1038. https://doi.org/10.1002/jso.70252

Vancouver

Duarte-Bateman D, Shen A, Chen Y, Arpi-Palacios J, Williams E, Patel V, et al. Indocyanine Green–Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients. Journal of Surgical Oncology. 2026;133(8):1031-1038. doi:10.1002/jso.70252

BibTeX
@article{DuarteBateman2026,
  author = {Duarte-Bateman, Daniela and Shen, Alan and Chen, Yanwen and Arpi-Palacios, Jorge and Williams, Eduardo and Patel, Viren and Knackstedt, Rebecca and Gastman, Brian R},
  title = {Indocyanine Green–Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {133},
  number = {8},
  pages = {1031--1038},
  doi = {10.1002/jso.70252}
}
Kostenlos starten →